Cop27: has there been any progress in Sharm el-Sheikh?

Loading player...
Cop27 got off to a difficult start last week. Attendees struggled with a lack of food and drink, civil society group events were curtailed, and more than 600 fossil fuel lobbyists hit the conference halls – more than the delegations of many of the most vulnerable countries combined. As we head into the second week, Madeleine Finlay hears from biodiversity reporter Patrick Greenfield about what it’s been like in Sharm el-Sheikh, and from environment editor Fiona Harvey about what’s happened so far and whether much progress is likely to be made in the final days of negotiations. Help support our independent journalism at theguardian.com/sciencepod
15 Nov 2022 English United Kingdom Science · Nature

Other recent episodes

Can a name change transform PCOS outcomes for women?

After more than a decade of global consultation, polycystic ovary syndrome – which affects as many as one in eight women – has been renamed. The condition is caused by high levels of androgens, which can lead to symptoms such as excess hair, weight gain and irregular periods. To understand…
21 May 16 min

Ebola outbreak: what do we know and can it be contained?

An outbreak of Ebola has emerged in the Democratic Republic of Congo and Uganda, which has led to nearly 400 confirmed cases and more than 100 deaths. To find out how the outbreak might have begun, what authorities can do to contain it and why this outbreak is causing particular…
18 May 13 min

Hantavirus update, Pentagon’s UFO files, can art slow biological ageing?

Madeleine Finlay sits down with co-host and science editor Ian Sample to discuss three eyecatching stories from the week, including an update on hantavirus. Also on the agenda is the Pentagon’s release of a tranche of never before seen documents relating to UFOs, and a study looking at the link…
14 May 21 min

Trump is backing psychedelic research: here’s why

Last month President Trump signed an executive order designed to fast track both research and access to psychedelic drugs as treatments for mental health illnesses. The most prominent in the order was ibogaine, a drug derived from the root bark of a West African shrub, that has shown some promise…
12 May 17 min